Organovo
a legacy pioneer focusing on 3D printed liver and intestinal models for highly predictive pharmaceutical toxicity testing.
- Country
- United States
- Ticker
- ONVO
tissues
us
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Organ & tissue bioprinting | regenerative-personalized | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.